REGN banks on Dupixent and Eylea HD gains to offset Eylea's decline while oncology wins strengthen its diversified pipeline.

NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Marex Group plc (NASDAQ: MRX) saw the price of their shares significantly decline in the wake of a critical short report accusing the company of engaging in an improper multi-year accounting scheme.

Applied Materials NASDAQ: AMAT gave its market a reason to sell with its Q3 results. However, the 15% pre-market decline is a knee-jerk reaction to news that opens up a solid buying opportunity.

Applied Materials topped Wall Street's third-quarter earnings estimates but issued light guidance due to macroeconomic pressures. CEO Gary Dickerson said the current macroeconomic backdrop and trade issues have fueled "increasing uncertainty and lower visibility," primarily within its China business

MTZ posts record Q2 results as AI-fueled fiber demand propels 42% growth in its Communications segment and a $5B backlog.

Sandisk (SNDK) shares slumped Friday, a day after the maker of computer flash drives gave lower-than-expected profit guidance as startup costs increase.

BOSTON, MASSACHUSETTS / ACCESS Newswire / August 15, 2025 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of private industrial wireless networks and commercial drone and automated data solutions through its Ondas Networks and Ondas Autonomous Systems business units, announced today the closing of its underwritten public offering of 53,084,000 shares of its common stock, which includes 6,924,000 shares of common stock sold pursuant to the exercise in full by the underwriter of their over-allotment option. Ondas estimates net proceeds from the offering to be approximately $163 million, after deducting underwriting discounts and commissions and estimated …

ImmuCell Corporation (NASDAQ:ICCC ) Q2 2025 Earnings Conference Call August 15, 2025 9:00 AM ET Company Participants Michael F. Brigham - President, CEO, Treasurer, Secretary & Director Timothy C.

AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.

PPG rides cost cuts, acquisitions and price hikes to offset weak demand in Europe and industrial coatings softness.

Robinhood's July DARTs surge across equities, options and crypto, as rapid product launches draw more active traders to its platform.

GAMR, ALAI, ARKX, PFI and ONLN shine as strong Q2 earnings lift sectors from gaming and AI to retail and aerospace.

AVB's prime-market portfolio and strong balance sheet support growth, but supply pressures and delayed development occupancies pose challenges.

WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a concern.

Unum Group sees Q2 premium gains, but rising costs, margin pressure, and weak ROE temper its performance.

ECG, NVT and HROW made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 15, 2025.

TRIB's needle-free CGM+ sensor shows accurate 15-day results with no calibration, slashing costs and boosting access.

BJ's (BJ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MEMPHIS, Tenn. , Aug. 15, 2025 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) announced today that Shaun McDougall has joined the organization as Head of Consumer Banking.